Mark Pruzanski

Insider Reports History

Location
New York, NY
Signature
/s/ Daniel M. Bradbury, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Pruzanski:

Form 4 holding Director

Equillium, Inc.

Security class
Director Stock Option (right to buy)
Shares / value
20,000
Estimated value
Report date
21 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Equillium, Inc.

Security class
Stock Option (right to buy)
Shares / value
20,000
Estimated value
Report date
22 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

INTERCEPT PHARMACEUTICALS, INC.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
08 Nov 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Mark Pruzanski

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .